Skip to content

Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury

Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00583804
Enrollment
10
Registered
2007-12-31
Start date
1989-04-01
Completion date
2027-09-30
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury, Tetraplegia

Keywords

Spinal Cord Injury, Tetraplegia, Functional Electrical Stimulation, Neuroprosthesis

Brief summary

The purpose of this study is to evaluate the effectiveness of an implanted stimulator and sensor for providing hand and arm function for individuals with cervical level spinal cord injury.

Detailed description

The design of this study is to determine the efficacy of improving upper extremity function in tetraplegic subjects after receiving an implantable device for neuromuscular control. Evaluations will be made so as to document changes in performance of manipulative tasks when using the stimulation system. Subjects who consent to participate in this project will have an implantable stimulator surgically placed in the upper extremity for control of the upper extremity. A series of tests will be performed before implantation, and repeated at intervals after implantation to assess changes in each subject's performance. This study is a non-randomized feasibility study with concurrent (neuroprosthesis on and off) and longitudinal (pre- and post-implantation/training) self-controls. Subjects participating in the study can expect to be actively involved in the study for two years after implantation and followed for life thereafter. The screening procedures take up to two days, depending on the specific evaluations necessary to determine candidacy. Pre-surgical exercise is conducted for at least two weeks. The implantation surgery itself lasts one day, with three to seven days of post-surgical hospitalization. Following an eight-week exercise program and a twelve-week training program, subjects are discharged from the active rehabilitation phase. They are followed quarterly for one year, and then annually thereafter. The device is referred to as the Implanted Stimulator-Telemeter (IST) -12. The device uses functional electrical stimulation (FES) to activate paralyzed muscles.

Interventions

DEVICEIST-12

Implanted stimulator and sensor device, with twelve implanted stimulating electrodes and two myoelectric signal recording electrodes.

Sponsors

Case Western Reserve University
CollaboratorOTHER
VA Office of Research and Development
CollaboratorFED
FDA Office of Orphan Products Development
CollaboratorFED
MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* C5-C8 spinal cord injury * Minimum of one-year post injury with no additional function prior to implantation surgery * Male or female * 18-60 years of age * intact vision * pharmacologically controlled spasticity, when applicable * Functional in wheelchair with adequate trunk support to allow bimanual manipulation * Positive attitude and motivation with supportive home environment * Willingness to return to laboratory for periodic evaluation and testing * Free of contractures known to diminish performance of the system (e.g., supination contracture of the wrist). * Integrity of the lower motor neuron (peripheral nerve) to the muscles to be activated * Adequate range of motion of joints of the shoulder, wrist, and hand (upper extremity). * If an acute infection is present, the subject will not be considered for surgery until it clears.

Exclusion criteria

* Prior history of a major chronic systemic infection or other illness that would increase the risk of surgery. * Contraindications include immunologic diseases, cardiac arrhythmias, undiagnosed or high-risk breast masses, dermatologic conditions, and any major system failure. * Acute infection currently present that has not cleared. * Hypersensitivity that inhibits their ability to sustain pressure over their digits. * Blind * Uncontrolled disorders, i.e., seizures

Design outcomes

Primary

MeasureTime frameDescription
Grasp-Release TestOne YearGrasp and Release Test (GRT) - The Grasp and Release Test (GRT) \[Wuolle, 1994; Smith et al., 1996; Carroll et al., 2000; Taylor et al., 2002; Mulcahey et al., 2004\], developed at the Cleveland FES Center, has been utilized by multiple centers to show improvements in hand function after implantation of a neuroprosthesis and tendon transfers \[Peckham, 2001\]. This pick-and-place test requires the participant to unilaterally acquire, move, and release six objects varying in weight and size. The objects are: 1) a small peg, 2) a wooden cube, 3) a small juice can, 4) a videotape, 5) a paperweight (\ 1000g) and a simulated fork task (spring-loaded plunger). The number of objects that the participant can successfully manipulate are scored. Success in manipulating each object in the GRT is defined as the ability to pick up and place the object at least once within 30 seconds.
Activities of Daily Living TestThree monthsThe ADL Abilities Test was developed to measure differences in activity performance with and without a hand neuroprosthesis. Scoring is based on an activity analysis approach. The activities, which are chosen by the participant, are broken down into phases, and each phase is scored for the amount of assistance the participant uses: 1) Physical Assistance (PA): assistance from an attendant, 2) Adaptive Equipment (AE): any modifications of the activity or its components, 3) Orthotic Assistance (OA): an orthotic device that the participant normally wears all day (e.g., a dorsal wrist support), and that can be considered a modification of the hand, 4) Self Assistance (SA): use of any part of the body other than the dominant hand, or use of the test equipment in an adapted way to complete the activity (e.g., using two hands to hold a glass, or sliding an object to the end of the table for grasping), and 5) Independent.

Secondary

MeasureTime frameDescription
Adverse EventsFrom date of implant until study completion or date of death from any cause.Self-reported adverse events.

Countries

United States

Participant flow

Participants by arm

ArmCount
Implanted Individuals
Individuals implanted with stimulator/sensor device. IST-12: Implanted stimulator and sensor device, with twelve implanted stimulating electrodes and two myoelectric signal recording electrodes.
10
Total10

Baseline characteristics

CharacteristicImplanted Individuals
Age, Continuous37 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Grasp-Release Test - Baseline2 Objects
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
10 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Activities of Daily Living Test

The ADL Abilities Test was developed to measure differences in activity performance with and without a hand neuroprosthesis. Scoring is based on an activity analysis approach. The activities, which are chosen by the participant, are broken down into phases, and each phase is scored for the amount of assistance the participant uses: 1) Physical Assistance (PA): assistance from an attendant, 2) Adaptive Equipment (AE): any modifications of the activity or its components, 3) Orthotic Assistance (OA): an orthotic device that the participant normally wears all day (e.g., a dorsal wrist support), and that can be considered a modification of the hand, 4) Self Assistance (SA): use of any part of the body other than the dominant hand, or use of the test equipment in an adapted way to complete the activity (e.g., using two hands to hold a glass, or sliding an object to the end of the table for grasping), and 5) Independent.

Time frame: Three months

ArmMeasureValue (MEDIAN)
Stimulation ONActivities of Daily Living Test6 Number of Tasks Improved
Primary

Grasp-Release Test

Grasp and Release Test (GRT) - The Grasp and Release Test (GRT) \[Wuolle, 1994; Smith et al., 1996; Carroll et al., 2000; Taylor et al., 2002; Mulcahey et al., 2004\], developed at the Cleveland FES Center, has been utilized by multiple centers to show improvements in hand function after implantation of a neuroprosthesis and tendon transfers \[Peckham, 2001\]. This pick-and-place test requires the participant to unilaterally acquire, move, and release six objects varying in weight and size. The objects are: 1) a small peg, 2) a wooden cube, 3) a small juice can, 4) a videotape, 5) a paperweight (\ 1000g) and a simulated fork task (spring-loaded plunger). The number of objects that the participant can successfully manipulate are scored. Success in manipulating each object in the GRT is defined as the ability to pick up and place the object at least once within 30 seconds.

Time frame: One Year

ArmMeasureValue (MEDIAN)
Stimulation ONGrasp-Release Test5.5 Number of Objects
Stimulation OFFGrasp-Release Test2 Number of Objects
Secondary

Adverse Events

Self-reported adverse events.

Time frame: From date of implant until study completion or date of death from any cause.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026